Micro-stratification refines risk maps for visceral leishmaniasis in Bangladesh, suggesting effective surveillance and resource allocation.
Background Bangladesh became the first country to achieve World Health Organization (WHO) validation for eliminating visceral leishmaniasis (VL, Kala-azar) as a public-health problem in 2023. Sustaining this milestone demands a post-validation surveillance strategy that concentrates its efforts on residual transmission foci and deploys resources efficiently. We therefore conducted the country’s first Mouza-level micro-stratification to refine risk maps and guide targeted interventions. Methods The study used routinely reported VL line-list data (2017-2022) from the national DHIS2 platform for every Upazila that recorded ≥1 VL case. Each Mouza—the smallest administrative unit—was categorised as high (≥3 new VL cases), moderate (2 cases), low (1 case) or non-endemic (0 cases) over the six-year period. Hot-spot maps were created in Python. Associations between endemicity (endemic vs non-endemic) and mean annual climate variables were tested with chi-squared statistics, yielding odds ratios (OR) with 95% confidence intervals (CI). Historical sand-fly density data from 51 purposively sampled Mouzas were compared across endemicity strata using one-way ANOVA. Among 15,982 Mouzas in 119 case-reporting Upazilas, only 428 (2.7%) reported ≥1 new VL case between 2017 and 2022. High-endemic Mouzas (n = 29; 0.18%) accounted for 36% of total incident cases and clustered primarily in Mymensingh, Dhaka and Rajshahi divisions. However, year-on-year mapping showed contraction of endemic Mouzas with no sustained new foci. Conclusions VL transmission in Bangladesh is now intensely focal, confined to <3% of Mouzas within historically endemic Upazilas. Restricting surveillance, IRS and active case detection through micro-stratification of endemic areas could largely cut vector-control costs while safeguarding elimination. Periodic updating Mouza-level risk maps and integrating high-resolution climate and entomological data will be essential to prevent resurgence and can serve as a model for other countries nearing VL elimination.
No takes yet. Share an insight, caveat, or question.
Maruf et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: